review · Tropical Diseases Travel Medicine and Vaccines
Oropouche fever represents a growing public health challenge across tropical and subtropical regions of Central and South America. Primarily transmitted by midges, the Oropouche virus circulates in both forested environments and urban settlements, triggering recurrent outbreaks that often go under-reported. Infected individuals typically experience febrile illness accompanied by headaches, muscle pain, and in rare cases, severe neurological conditions such as meningitis. Because there are currently no specific antiviral treatments or licensed vaccines available, clinical management relies heavily on general care. Climate change presents a significant risk of expanding vector habitats into previously unexposed territories. Addressing this threat requires urgent investment in molecular diagnostic tools, advanced vector control methods, sustained epidemiological surveillance, public education campaigns, and cross-border partnerships to contain the transmission of the virus and manage future disease outbreaks effectively.
Oropouche fever is an escalating vector-borne illness that causes severe fever and occasional neurological disorders. Without licensed vaccines or targeted therapies, tracking and treating infections is difficult. As climate shifts threaten to enlarge midge habitats, the virus could spread far beyond its current South and Central American boundaries, creating urgent challenges for global public health systems and disease control programmes.
The work points to opportunities for diagnostic developers and vector management enterprises. Specifically, it highlights the need for advanced molecular diagnostics to overcome current under-reporting and improve clinical detection, alongside novel vector control strategies targeting midges. These application pathways remain at an early, research and development stage, given the current absence of dedicated commercial vaccines, targeted therapies, or standardised diagnostic kits noted in the abstract.
AI-generated from the published abstract. Always read the original work before citing.
Oropouche fever is an increasingly significant health concern in tropical and subtropical areas of South and Central America, and is primarily spread by midge vectors. The Oropouche virus (OROV) was first identified in 1955 and has been responsible for numerous outbreaks, particularly in urban environments. Despite its prevalence, the disease is often under-reported, making it difficult to fully understand its impact. OROV typically causes febrile illness characterized by symptoms such as headaches, muscle pain, and, occasionally, neurological issues such as meningitis. The ability of the virus to thrive in both forested and urban areas has raised concerns regarding its potential spread to new regions, particularly in the context of climate change. This paper delves into the epidemiology, clinical features, and transmission patterns of OROV, shedding light on the difficulties in diagnosing and managing the disease. The absence of specific treatments and vaccines highlights the urgent need for continued research and development of targeted public health strategies. Advancements in molecular diagnostics and vector control strategies can mitigate Oropouche fever's impact. However, a comprehensive public health approach involving increased surveillance, public education, and cross-border collaboration is needed, especially as the global climate crisis may expand vector habitats, posing risks to previously unaffected regions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s40794-024-00236-x
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
